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Abstract
Background: The aim of this experimental study was to determine the effect of mild hyperthermia on tumor
response and angioneogenesis in an isolated limb perfusion model with a human melanoma xenograft.
Methods: A human melanoma xenograft was implanted into the hindlimbs of 30 athymic nude rats. The animals
were randomized into five groups: group I: control, group II: sham group, group III: external hyperthermia with a
tissue temperature of 41.5°C for 30 minutes without ILP, group IV: normothermic ILP (tissue temperature 37°C
for 30 minutes, group V: hyperthermic ILP (tissue temperature 41.5°C for 30 minutes). Tumor response was
evaluated by tumor size determination and immunohistochemical analysis 6 weeks postoperatively. Tissue
sections were investigated for expression of CD34 and basic fibroblast growth factor (bFGF).
Results: Average tumor volumes of the controls (I) increased from 105 mm3 to 1388 mm3. In the sham operated
group (II) tumor volumes were significantly larger than in group I. Tumor volumes in group IV were significantly
smaller than in group I and lowest in group V. There were no significant differences in size between group I and
group III after six weeks. In group III and IV each, 5 animals showed tumor progression and one had a partial tumor
response. In group V only 2 animals showed tumor progression. Immunhistochemical analysis of the tissue
sections demonstrated that angioneogenesis was more pronounced in group II than in group I and less
pronounced in group IV and V compared with group I.
Conclusions: Our results suggest that even a surgical manipulation such as a skin incision promotes tumor
growth, probably by induction of growth factors like bFGF.
External hyperthermia of 41.5°C tissue temperature for 30 minutes only has no impact on tumor growth and 
angioneogenesis in vivo.
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Background
Hyperthermic isolated limb perfusion is an established
treatment for multiple, locoregional intransit metastases
of malignant melanoma and soft tissue sarcomas of the
extremities. It was introduced 1957 by Creech and Kre-
mentz [1]. The procedure allows a high locoregional con-
centration of cytostatics with few systemic side effects [2].
Isolated limb perfusion achieves local tumor control in a
high percentage of cases. Complication rate of perfusion
is acceptably low. A surviving model for isolated perfused
rat hindlimbs was reported by Wu et al. [3] based on the
perfusion model of Nagel et al.[4].
Angioneogenesis has been recognized for many years to
play a central role in the growth of primary tumors and
the formation of metastases in general [5,6]. Melanomas
express basic fibroblast growth factor (bFGF) and fibrob-
last growth factor receptor-1 (FGFR-1) in their dermal
nevocytes and in the stroma. bFGF promotes angiogenesis
in vivo [7] and in vitro [8]. Antisense targeting of bFGF/
FGFR-1 in malignant melanomas blocks intratumoral
angioneogenesis [9].
Hyperthermia inhibits angioneogenesis. Some of the anti-
neoplastic effects of hyperthermia are caused by ischemia
due to obstruction or destruction of the tumor vessels.
Eikesdal et al. described by hyperthermic temperatures
disrupture of 25–50 % of the vasculature in malignant
tumors. The heated tumors (44°C) had a blood flow
reduction of 40–60 % after 24 hours [10].
In vitro data indicate that capillary endothelials cells of
malignant neoplasms are more thermosensitive than
endothelial cells of normal tissues. The vascularization of
tumors can be significantly damaged at temperatures
which may alter but do not damage the vasculature of nor-
mal tissue [11]. The extent of the proliferation of vessels is
also inversely related to temperature [12]. The critical tem-
perature at which a direct vascular damage occurs is
between 42.7 and 43.7 degrees C [13].
Hyperthermia increases the effects of angioneogenesis
inhibitors on tumor growth and tumor angioneogenesis
[14]. The aim of this experimental study was to determine
the impact of hyperthermia on tumor response and angio-
neogenesis in an isolated limb perfusion model.
Methods
Thirty inbred male nude athymic rats (Rowett rnu/rnu)
weighting 200 to 280 g were used in this study. Animals
were kept separately during the experiment with 12 hours
of light per day. They were fed a standard laboratory diet
and tap water ad libidum. Maintenance and care of all
experimental animals were carried out according to the
guidelines of the local responsible Animal Protection
Commission and carried out in compliance with national
guidelines (National Institute of Health for Use of Labo-
ratory Animals).
A solid sample (2 × 2 × 2 mm) of a human melanoma
xenograft (SK-MEL-3), derived from a lymph node
melanoma metastasis, was implanted into the hindlimbs
of 30 nude rats. The largest width and the maximum
tumor diameter perpendicular to the width were meas-
ured with a micrometer. Only tumors with a diameter
greater than > 12 mm in the largest diameter were
included in the study.
The details of the perfusion system have been described
previously [4]. The equipment consisted of a miniature
oxygenator, a heat exchanger and a roller pump. Venous
blood of the limb was oxygenated in the oxygenator
(99.15% O2; 0.85% CO2) and warmed in the heat
exchanger. The warmed arterialized perfusate is driven by
a roller pump with two synchronously running pump-
heads on a single axis for the arterial and venous lines
(Masterflex®). The outer diameters of the tubes corre-
sponded with the diameter of the femoral vessels of nude
rats weighting about 250 g (arterial 0.7 mm; venous 1.0
mm).
Rat hindlimbs were perfused with ringer's solution and
sodium heparin (25 IU/100 µl saline) at 37 or 41.5
degrees C for 30 minutes with a flow rate of 4 ml/min.
External hyperthermia was applied by an infrared lamp
positioned in a fixed distance to the tumor.
For temperature measurement during limb perfusion, a
nickel-chrom-nickel thermocouple of 0.6 mm in diameter
(Standard Integrated Thermocouple Thermocoax, Phil-
lips, Hamburg, Germany) was placed at the macroscopic
tumor margin. The thermocouple was calibrated before
use in a high-precision water bath. Baseline temperature
was recorded for 5 minutes before treatment. Temperature
was continuously measured during application. In group
I (control) and group II (sham operated) temperature
measurement was not performed.
The animals were randomized into a control and four
study groups of six animals each: group I: control (no
therapy), group II: sham group (skin incision without
ILP), group III: external hyperthermia with a tissue tem-
perature of 41.5°C for 30 minutes without ILP, group IV:
normothermic ILP (Ringer's solution as perfusate, tissue
temperature 37°C for 30 minutes, group V: hyperthermic
ILP (tissue temperature 41.5°C for 30 minutes). ILP was
subsequently performed with the above-mentioned
parameters. Antineoplastic agents were not applied.BMC Cancer 2004, 4:53 http://www.biomedcentral.com/1471-2407/4/53
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The rats were anaesthetized with Ketamin (Ketanest®, 80
mg/kg i.m.; Pearl-Davis, Berlin, Germany) and Xylazin
(Rompun®, 10 mg/kg i.m.; Bayer, Leverkusen, Germany),
and fixed in a supine position. For perfusion, the animals
underwent a 3-cm incision of the groin. The left femoral
artery and vein were isolated using an operation micro-
scope. A vascular clip was placed across the artery and a
silicon catheter (outer diameter 0.7 mm) was introduced
via a transverse arteriotomy. The femoral vein was cannu-
lated with a silicon catheter of 1 mm outer diameter (Fig.
1). Tourniquets were applied around the left hindlimb to
ensure isolation. Rat hindlimbs were perfused at a flow
rate of 4 ml/h, for 30 min. After treatment, the silicon
catheters were removed, and the vein and the artery were
sutured (8/0 Prolene), to restitute normal blood flow.
After the isolated limb perfusion the wound was closed in
two layers. Total operation time rated about 90 min.
During the first 5 days after operation the rats were
weighed daily, and once a week there-after. The animals
were kept under standardized conditions and were killed
by an overdose of anesthetic and cervical dislocation 6
weeks after treatment. The greatest tumor width and the
maximum diameter perpendicular to the width were mac-
roscopically measured with a micrometer. Lesion volume
was calculated using the formula v = 4 × π × a × b 2/3, in
which a and b are the radii of the measured axes. The
tumor was then completely sectioned. Each tumor was
divided into two parts. One part was fixed in 4 per cent
formalin solution for 5 days, embedded in paraffin and
stained with hematoxylin and eosin (H&E). The other
part was fixed in 0.9 % saline solution, frozen and stored
at -80°C until use.
Vascular density and tumor morphology were evaluated
by immunohistochemistry. Tumor tissue was tested for
expression of basic fibroblast growth factor (bFGF) and
CD34.
Tissue specimens were fixed in 10 % formaldehyde and
embedded in paraffin according to routine protocols. Sec-
tions 4 µm thick were deparaffinized and rehydrated
using graded ethanols following routine protocols. For
antigen retrieval all sections were microwave treated for
20 minutes in target retrieval solution (for bFGF; DAKO,
Glostrup, Denmark) or 10 mM citrate buffer (for CD34)
at 700 W. The sections were incubated overnight with pri-
mary mouse anti-bFGF (1:50; Becton Dickinson, Heidel-
berg, Germany) and anti-CD34 antibody (1:100;
Immunotech, Hamburg, Germany). After rinsing in Tris
buffer detection was carried out with a biotinylated sec-
ondary rabbit anti-mouse antibody diluted 1:50 (DAKO,
Glostrup, Denmark) for 30 minutes at room temperature.
The sections were washed again as above in Tris buffer and
then incubated with streptavidin-biotin-alkaline-phos-
phatase (10 µl each solution A+B (Sigma, Deisenhofen,
Germany) in 10 ml Tris). Immunohistochemical staining
was visualized with Fast Red (2 mg Naphtol-As-Mx-phos-
phate, 10 µl 1 M Levamisol and 10 mg Fast-Red (Sigma)
in 0.2 ml N, N-dimethylformamide, (Merck, Darmstadt,
Germany) and 9.8 ml 0.1 M Tris-HCl buffer at pH8.6).
The sections were rinsed in H20 and counterstained with
hemalaun. Negative controls without primary antibody
were run for each sample.
Tumor response was graded according to the system
described by de Wilt et al. [15]. Progressive disease (PD)
was defined as a tumor size > 125 % of the size at the time
of treatment, in tumor sizes of 100 ± 25 % no change
(NC) was stated. Response was graded as partial (PR) if
tumor sizes was between 10 and 75 % and complete (CR)
for tumor size < 10 % of its original diameter.
In areas of intense neovascularized spots microvessels
were counted in a 100× field. A microvessel was defined
as a lumen surrounded by a rim of endothelial cells high-
lighted by immunostaining with anti-CD34 antibodys or
anti-bFGF antibodys. Five separate intense neovascular-
ized areas were assessed, and the mean was calculated as
microvessel density of each tumor. The score was assessed
by two independent observers.
Data were analyzed using SPSS/PC+ statistical software.
The mean and range of tumor and lesion volumes were
calculated for each group. For comparison of tumor vol-
ume and microvessel density between the diffent groups a
Diagrammatic outline of the experimental setup Figure 1
Diagrammatic outline of the experimental setup. 1: roller 
pump system; 2: bubble oxygenerator; 3: heat exchanger, T: 
temperature
37 - 42,5 ° C
2
1 3
von
art.
T
P
O
T 1: roller pump system
2: bubble oxygenerator
3: heat exchanger
T: temperature
P: pressureBMC Cancer 2004, 4:53 http://www.biomedcentral.com/1471-2407/4/53
Page 4 of 9
(page number not for citation purposes)
non-parametric test was used (Kruskal-Wallis). A p value
< 0.05 was considered to be significant.
Results
During intervention, the required limb tissue temperature
was reached within 8–12 minutes in group IV and 10–15
minutes in group III. Stable temperatures were then main-
tained for a further 30 minutes with a mean of 41.4°C ±
0.5. To reach limb tissue temperature the perfusion fluid
maintained 43°C ± 0.4.
Tumor and lesion Volumes
Before treatment, the mean (s.e.m) volume of the treated
tumors in groups I, II, III, IV and V was 105 mm3 (4.3), 98
mm3 (5.7), 108 mm3 (3.4), 95 mm3 (5.0) and 107 (4.1)
mm3 respectively, with no significant difference between
the groups. Average tumor volume of the controls (I)
increased to 1388 mm3 (101) during six weeks. In the
sham operated group (II) tumor volume was significantly
larger than in group I (2350 mm3 (198.6), P = 0.021).
Tumor volume in group IV was significantly smaller
(1009 mm3 (122.5)) than in group I and lowest in group
V 405 mm3 (103.6) (P= 0.036 and P= 0.021, respec-
tively.). There were no significant differences in size
between group I and group III (1135 mm3 (99)) after six
weeks (P > 0.05)(Fig. 2).
Body weight
After the perfusion, body weight decreased in all groups
during the first 5 days with a maximum of 8 %. In the fol-
lowing weeks, body weight mounted up to 130 % of the
preoperative value. In the last week of the experiment, the
weight almost reached a plateau. No significant differ-
ences between the five experimental groups were found.
Histology
In the H&E staining the untreated melanoma (group I)
presented as a subcutanous unilocular nodule of moder-
ate differentiation. The tumor showed mainly tubular
structures with vacuole like lumen formation and was
infiltrated with fibrous septa. The spontaneous rate of
necrosis was estimated to be 20 %. Numerous mitoses
were detected. Tumor morphology did not change with
ageing or tumor size. Histology was similar in group II.
In group V the tumors showed signs of irreversible cell
damage after treatment. Tumor cells displayed clear
shrinkage and partial loss of cell contact. Thromboses of
the larger adjacent vessels were found on the tumor-skin
border. Macrophage infiltration was present in all groups,
but was more numerous pronounced in group V. In group
III and IV there were less signs of irreversible cell damage
after treatment than in group V.
Immunhistochemical analysis of the histological sections
for bFGF demonstrated that microvessel density of group
I (Fig 3) ranged from 18 to 23 with a mean value of 20.
Angioneogenesis was more pronounced in group II (Fig
4) than in group I (p = 0.003) and less pronounced in
group IV and V (Fig 5) compared with group I (p = 0.023,
p = 0.001). There were no significant differences in the
expression of angiogenetic markers between group I and
group III (p >0.05).
Immunhistochemical analysis of the histological sections
for CD34 showed that microvessel density of group I
ranged from 17 to 23 with a mean value of 19. Angioneo-
genesis was more pronounced in group II than in group I
(p = 0,001) and less pronounced in group IV and V com-
pared with group I (p = 0.023, p = 0.017). There were no
significant differences in the expression of angiogenetic
markers between group I and group III (p > 0.05).
Strong expression of bFGF and CD34 was found in the
cytoplasm of intimal endothelial and medial smooth
muscle cells. Expression of bFGF and CD34 was stronger
at the invasion front than in the centre of tumors.
Summarized data of the expression intensity of bFGF and
CD34 in the tumors are given in table 1.
Tumor remission
In group I and II tumor progression was observed in all
animals macro- and microscopically. In group III and IV 5
animals showed tumor progression and one had a partial
The mean tumor volumes + SEM of groups I to V (n = 30) 6  weeks after treatment; Group II, III, IV and V compared to  group I (§: P = 0.036 ; #: P = 0.021 (Kruskall-Wallis) n.s.:not  significant) Figure 2
The mean tumor volumes + SEM of groups I to V (n = 30) 6 
weeks after treatment; Group II, III, IV and V compared to 
group I (§: P = 0.036 ; #: P = 0.021 (Kruskall-Wallis) n.s.:not 
significant).
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tumor response. In group V, 2 animals showed tumor
progression, 2 had a complete remission. One had a par-
tial tumor response and one had no change in tumor
response (table 2).
Discussion
A phenomenon that has been described by numerous
authors is the rapid increase of tumor growth following
surgical manipulation [16,17].
This was also observed in our sham-operated group of
animals (group II) in which tumors grew more rapidly
than in the control group (group I). This implies that
resection is associated with an accelerated growth in resid-
ual tumors. It is assumed that the surgical manipulation
induces liberation of growth factors that in addition to
their effect on healing also have a stimulating effect on
tumor proliferation.
This hypothesis is supported by the results of our immu-
nohistochemical investigations, which revealed an
enhanced expression of fibroblast growth factor (bFGF) in
group II. In an intraperitoneal tumor model, EGGER-
MONT et al. showed that the surgical intervention of
laparotomy induces an increase of carcinomatosis in the
entire peritoneal cavity. At the same time, the immuno-
therapeutic effect of interleukin 2 and natural killer cells is
significantly reduced. It must therefore be speculated that
surgical trauma induces a temporary immunosuppressive
effect that influences tumor growth [16,18,19].
Immunohistochemical staining for bFGF in group I (control): Microvessels are represented by red clusters, which stand out  sharply from other tissues Figure 3
Immunohistochemical staining for bFGF in group I (control): Microvessels are represented by red clusters, which stand out 
sharply from other tissues.BMC Cancer 2004, 4:53 http://www.biomedcentral.com/1471-2407/4/53
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In our experiments, group V (hyperthermic perfusion)
showed a significant slowing of tumor growth in compar-
ison with the control group. This was also confirmed by
the immunohistochemical investigations that showed a
reduction in the expression of relevant markers of the vas-
cular endothelium. Indeed, two of the six animals
occurred a complete remission of their tumor. The obser-
vation that two animals in this group experienced tumor
progression can probably be explained by the duration of
the intervention, since factors affecting the kinetics of cell
death during hyperthermia are not only the maximum
temperature induced, but also the duration of the elevated
temperature.
In an overview report BHUYAN noted that, as a function
of various tumor cell types, a temperature of 43°C must
be applied between 30 and 150 minutes to irreversibly
damage the tumor cells. At a temperature of 45°C, the
application time required varied between 13 and 85 min-
utes [20]. In our experiments, the application time was
only 30 minutes at a temperature of 41.5°C. Nevertheless,
the relatively short application time also had an apprecia-
ble damaging effect on the metastatic vessels.
Although the temperature in group III (external hyper-
thermia) was also 41.5°C applied for 30 minutes, no sig-
nificant changes in the growth pattern of the tumor could
Immunohistochemical staining for bFGF in group II (sham operated): More microvessels are represented in the margin of the  tumor Figure 4
Immunohistochemical staining for bFGF in group II (sham operated): More microvessels are represented in the margin of the 
tumor.BMC Cancer 2004, 4:53 http://www.biomedcentral.com/1471-2407/4/53
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be observed. Furthermore, the histological and immuno-
histochemical evaluations showed a mild hyperthermic
damage at best. A comparison of treatment groups III and
V revealed no differences in terms of duration of treat-
ment and induced tissue temperatures.
In contrast to group III, however, hyperthermia in group
V has been mediated directly by the vascular system. In
normal tissues subjected to warming, blood perfusion
increases reactively via dilatation of the vessels together
with an increase in vessel wall permeability. A decisive fac-
tor is that the tumor cells themselves, as well as the
endothelial cells of tumor vessels are more thermosensi-
tive than normal tissue [16,21,22]. Other authors have
also shown that hyperthermia is capable of destroying
vascular architecture, so that perfusion of the tumor is
reduced. The sensitivity of various tumors, however, varies
considerably [14]. ILP and other vasculotoxic effects like
TNFalpha in combination with melphalan or doxorubicin
increase the uptake of these drugs of three to six times
[23].
Heat transfer between the vascular system and the tissue is
determined in particular by the nature of the blood ves-
sels. Important factors are the number, length, and diam-
eter of the vessels, and also the velocity of blood flow [24].
CREZEE described the relationship between tumor
perfusion and heating of the tumor tissue under systemic
hyperthermia. He could show that the induction of heat
in the tumor depends on the density of the blood vessels
within the tumor itself. The more vessels in the tumor
exist, the easier it is to heat the lesion via the vascular sys-
tem. Heattransfer is particularly pronounced with large-
calibre blood vessels or high flow velocity, and its rate is
Immunohistochemical staining for bFGF in group V (HILP): Angioneogenesis is less pronounced as in group I Figure 5
Immunohistochemical staining for bFGF in group V (HILP): Angioneogenesis is less pronounced as in group I. Brown clusters 
represent melanin.BMC Cancer 2004, 4:53 http://www.biomedcentral.com/1471-2407/4/53
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all the greater the higher the temperature gradient
between the tumor tissue and the blood [25,26].
On the other hand, tumor vasculature carries away the
externally applied heat (group III) which is then no longer
available to destroy the tumor cells. In this case, the tem-
perature gradient decreases from the tumor to the vascular
system.
Furthermore, in the presence of hyperthermia, microcir-
culation in the tumor tissue is more affected than in nor-
mal tissue [27]. In addition, manipulation to the vascular
system, and thus oxygenation of the tumor, also appears
to play an important role. Although the body's own oxy-
genated blood is added to the perfusate, the dilution effect
together with the clamping time, leads to a relative reduc-
tion in perfusion. It is known that hypoxia, in conjunction
with a decrease in the pH and energy status of the cell,
enhances thermosensitivity [28-30], and this increase cor-
relates with the size of the tumor [31].
Our results have also confirmed that surgical manipula-
tion of the vascular system and perfusion have an influ-
ence on the tumor. Overall, the effect of the intravascular
application of hyperthermia appears to be mediated by a
combination of hypoxia and heat.
Conclusions
Our results suggest that even a surgical manipulation such
as a skin incision promotes tumor growth, probably by
induction of growth factors like bFGF. External hyperther-
mia of 41.5°C tissue temperature for 30 minutes has no
impact on tumor growth and angioneogenesis in vivo.
Hyperthermic isolated limb perfusion effectively sup-
presses tumor angioneogenesis respectively tumor
growth.
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Table 1: Summarized data of the expression intensity of bFGF and CD34
CD34 P to group I bFGF P to group I
group I 19 ---- 20 ----
group II 28 0.001 26 0.003
group III 20 > 0.05 21 > 0.05
group IV 27 0.023 26 0.023
group V 16 0.017 16 0.001
Table 2: Tumor response to treatment of isolated limb perfusion. Tumor diameters were measured and expressed as a percentage of 
the size at the time of treatment.
response group I group II group III group IV group V
complete 0/6 0/6 0/6 0/6 2/6
partial 0/6 0/6 1/6 1/6 1/6
no change 0/6 0/6 0/6 0/6 1/6
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